Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors

SIMPLE SUMMARY: The search for serum biomarkers of inflammatory activity in patients with immune-mediated diseases is an area of interest and has been the subject of multiple investigations in recent years. Calprotectin is a biomarker that can be used to identify inflammation and tissue damage and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Frade-Sosa, Beatriz, Chacur, Chafik Alejandro, Augé, Josep M., Ponce, Andrés, Sarmiento-Monroy, Juan C., Azuaga, Ana Belén, Sapena, Nuria, Ramírez, Julio, Ruiz-Esquide, Virginia, Morlà, Rosa, Farietta, Sandra, Corzo, Patricia, Cañete, Juan D., Sanmartí, Raimon, Gómez-Puerta, José A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251936/
https://www.ncbi.nlm.nih.gov/pubmed/37296947
http://dx.doi.org/10.3390/cancers15112984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251936/
https://www.ncbi.nlm.nih.gov/pubmed/37296947
http://dx.doi.org/10.3390/cancers15112984

Ejemplares similares